Safety/Efficacy Study of Optimizing Ibuprofen Dosing to Achieve Higher PDA Closure Rates

Summary

The purpose of this study is to determine if increasing the ibuprofen dose will increase the likelihood of closing the patent ductus arteriosus in premature babies.

Timeline

Start

2009-08

Primary completion

2010-10

Completion

2010-10

Outcome

Outcome not reported

Stopped: “FDA drug recall on July 30, 2010”

Drugs

Indications